Evidence map›Paper›PMID 38077339›Full record

ArticleFrontiers in immunology2023

Wei Zhang, Eun-Koung An, So-Jung Kim, Hae-Bin Park, Peter C W Lee, Jun-O Jin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Genomic Characterization ofMicroorganisms · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Wei ZhangShanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai, China.
Eun-Koung AnDepartment of Microbiology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
So-Jung KimDepartment of Microbiology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Hae-Bin ParkDepartment of Microbiology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Peter C W LeeDepartment of Biochemistry and Molecular Biology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Jun-O JinDepartment of Microbiology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
University of Ulsan · KRUlsan College · KRShanghai Public Health Clinical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Immune stimulators are used to improve vaccine efficiency; however, they are accompanied by various side effects. In previous studies, we reported that the Methods: FimH was administered orally or intraperitoneally ( Results: FimH oral and Conclusion: This study demonstrated the side effects of FimH and indicated that the use of FimH can aggravate the disease in patients with colitis.

Indexed as

ColitisDendritic CellsAnimalsAntigens, CDCD11b AntigenHumansInflammationIntegrin alpha ChainsMiceMice, Inbred C57BLalpha E integrinsAntigens, CDCD11b AntigenIntegrin alpha ChainsItgam protein, mousecolitisdendritic cellFimHTh1Th17

Identifiers

PMID38077339
PMCPMC10703180
OpenAlexW4388964086

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.